Published in Blood Weekly, December 11th, 2003
"Previously, we reported the identification of autoantibodies against the melanin-concentrating hormone receptor 1 (MCHR-1) in patients with vitiligo. In this study, the B cell epitopes on MCHR-1 that are recognized by these autoantibodies have been identified," scientists writing in the Journal of Investigative Dermatology report.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.